← Back to list
Transcatheter and Device Based Hemodynamic Management Procedures - Medicare Advantage (Revised)
Effective date
Nov 2, 2026
Identified
Nov 3, 2026
Summary
Humana's Medicare Advantage policy on transcatheter and device-based hemodynamic procedures (policy HUM-1045-011) was revised with an effective date of 11/02/2026. The change summary lists this revision as an annual review with no coverage change, so the existing position carries forward: Humana states that implanted IVC and left atrial pressure monitors, and the subcutaneous heart failure decompensation monitor, are not medically reasonable and necessary. Carotid sinus baroreflex therapy has stated clinical criteria, and renal denervation and pulmonary artery pressure sensors follow CMS national coverage determinations 20.40 and 20.36.
Get alerts when payers change rules like this one
We check Humana and other payers every day and email you when a change matches your specialty and state.
Get Humana alertsPolicy Monitoring is free. No card required.
What to do
Action · 6 steps
01Already effective 11/02/2026, with no coverage change in this revision: Billing team and providers, for Humana Medicare Advantage members, stop scheduling and billing implanted IVC monitoring (0981T, 0982T, 0983T), left atrial pressure monitoring (0933T, 0934T), and subcutaneous heart failure decompensation monitor insertion and removal (1050T, 1051T), because the policy states these will not be considered medically reasonable and necessary.
02Flag these services in the schedule and in charge entry so none are booked for these members without a provider review.
03For carotid sinus baroreflex therapy (64654 through 64659, 93145, 93146, C1825), have providers document the policy criteria before scheduling: enrollment in an approved category B IDE study, or symptoms despite optimal therapy with LVEF of 35 percent or less, NT-proBNP under 1600 pg/mL, NYHA class III or II with recent class III, and none of the listed contraindications.
04For renal denervation (C1735, C1736, 0338T, 0339T) and pulmonary artery pressure sensors (33289, 93264, C2624, G0555), follow CMS NCD 20.40 and NCD 20.36 and confirm current status in the CMS coverage database.
05The policy states that services not meeting these criteria are not medically necessary.
06Watch for Humana's next revision of this policy.
Codes mentioned
3328993264C2624G0555C1735C17366465464655646566465764658646599314593146C182593799
Original notice
Transcatheter and Device Based Hemodynamic Management Procedures - Medicare Advantage (Revised)
mcp.humana.com · Always check the source before changing claims.
Related changes
See all Humana changes →Transcatheter and Device-Based Hemodynamic Management Procedures - Medicare Advantage (Revised)MediumEffective Aug 3, 2026 · Medicare AdvantageTranscatheter and Device-Based Hemodynamic Management Procedures - Medicare Advantage (Revised)MediumEffective May 1, 2026 · Medicare AdvantageCardiac Devices - MEDICAID - VIRGINIA (Revised)MediumEffective Oct 28, 2026 · MedicaidCardiac Devices - MEDICAID - VIRGINIA (Revised)HighEffective Mar 9, 2026 · MedicaidBrowse every Humana change in the policy list